ACLY: A biomarker of recurrence in breast cancer.
Pathology - Research and Practice(2020)
摘要
•ACLY is significantly upregulated in breast cancer tissue.•ACLY expression is associated with poor prognosis-associated clinical variables.•Upregulated ACLY predicts worse relapse-free survival of breast cancer patients.•ACLY over-expression induces the resistance of breast cancer cells to docetaxel.
更多查看译文
关键词
ACLY,Breast cancer,Recurrence,Prognosis,Drug resistance
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要